ATE343389T1 - Inositolderivatisierte phospholipide - Google Patents

Inositolderivatisierte phospholipide

Info

Publication number
ATE343389T1
ATE343389T1 AT03778325T AT03778325T ATE343389T1 AT E343389 T1 ATE343389 T1 AT E343389T1 AT 03778325 T AT03778325 T AT 03778325T AT 03778325 T AT03778325 T AT 03778325T AT E343389 T1 ATE343389 T1 AT E343389T1
Authority
AT
Austria
Prior art keywords
phospholipid
phospholipides
inositol
derivatized
medicament
Prior art date
Application number
AT03778325T
Other languages
English (en)
Inventor
Kerstin Danker
Michael Mickeleit
Dieter Mueller
Werner Reutter
Original Assignee
Charite Universitaetsmedizin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Charite Universitaetsmedizin filed Critical Charite Universitaetsmedizin
Application granted granted Critical
Publication of ATE343389T1 publication Critical patent/ATE343389T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
AT03778325T 2002-11-20 2003-11-20 Inositolderivatisierte phospholipide ATE343389T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02025673A EP1421941A1 (de) 2002-11-20 2002-11-20 Phospholipide mit einem polyhydroxylierten alizyclischen Gruppe

Publications (1)

Publication Number Publication Date
ATE343389T1 true ATE343389T1 (de) 2006-11-15

Family

ID=32187162

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03778325T ATE343389T1 (de) 2002-11-20 2003-11-20 Inositolderivatisierte phospholipide

Country Status (9)

Country Link
US (1) US7465817B2 (de)
EP (2) EP1421941A1 (de)
JP (1) JP4511365B2 (de)
AT (1) ATE343389T1 (de)
AU (1) AU2003285337A1 (de)
CA (1) CA2506084A1 (de)
DE (1) DE60309345T2 (de)
ES (1) ES2275127T3 (de)
WO (1) WO2004045623A1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897385A (en) * 1984-12-10 1990-01-30 American Cyanamid Company Antihypertensive phosphate derivatives
US4697031A (en) * 1984-12-10 1987-09-29 American Cyanamid Company Antihypertensive phosphate derivatives
CH683671A5 (it) * 1992-03-30 1994-04-29 Golgi Sa Uso topico di glicerofosfolipidi deacilati.
US6559099B1 (en) * 2000-03-29 2003-05-06 Wisconsin Alumni Research Foundation Methods for enhancing plant health, protecting plants from biotic and abiotic stress related injuries and enhancing the recovery of plants injured as a result of such stresses

Also Published As

Publication number Publication date
EP1562609A1 (de) 2005-08-17
AU2003285337A1 (en) 2004-06-15
US20060105996A1 (en) 2006-05-18
US7465817B2 (en) 2008-12-16
JP2006514625A (ja) 2006-05-11
CA2506084A1 (en) 2004-06-03
DE60309345T2 (de) 2007-05-31
EP1562609B1 (de) 2006-10-25
WO2004045623A1 (en) 2004-06-03
ES2275127T3 (es) 2007-06-01
EP1421941A1 (de) 2004-05-26
DE60309345D1 (de) 2006-12-07
JP4511365B2 (ja) 2010-07-28

Similar Documents

Publication Publication Date Title
BRPI0413490A (pt) novos compostos
BR0116052A (pt) imidazoquinolinas substituìdas por éter arìlico
CY1109457T1 (el) Παραγωγο aminoαλκοολης ή παραγωγο φωσφονικου οξεος και φαρμακευτικη συνθεση που τα περιεχει
CR10271A (es) Formulaciones para uso veterinario que contienen productos de orgen no animal (divisional)
IL193074A0 (en) Stable pharmaceutical formulations of montelukast sodium
ECSP066383A (es) Derivados de 5-fenil-4-metil-tiazol-2-il-amina como inhibidores de enzimas de cinasa fosfatidilinositol 3 (pi3) para el tratamiento de enfermedades inflamatorias de las vías respiratorias
BR0113989A (pt) Compostos, composições farmacêuticas, processo para a preparação de uma composição farmacêutica, e, uso de pelo menos um dos compostos
DE60232653D1 (de) Pharmazeutisch wirksame uridinester
AR025444A1 (es) Derivados de sulfonil-carboxamida, procedimientos para su preparacion y su utilizacion como medicamentos
ES2190396T3 (es) Nuevos compuestos amino-triazoles, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
BR0206381A (pt) Derivados do ácido fumárico como inibidor de nf-kappab
BR0315296A (pt) Derivados do ciclohexanol espirocìclicos
MXPA03002779A (es) Derivados de glucopiranosiloxibencilbenceno y composiciones medicinales conteniendo los mismos.
BR0306870A (pt) Composição farmacêutica oral, e, método para preparar a mesma
DK1675591T3 (da) Farmaceutisk sammensætning omfattende en monoamin-neurotransmitter-genoptagelseshæmmer og en acetylcholinesterase-hæmmer
AR004158A1 (es) Compuesto de ftalizin-pirido dionas; composición farmacéutica que lo contiene; y proceso para la preparación de dicho compuesto.
BRPI0514448A (pt) derivados do ácido bifenil-oxiacético para uso no tratamento de doenças respiratórias
ECSP045493A (es) Nuevas composiciones farmacéuticas que contienen flibanserina polimorfo a
BRPI0416287A (pt) compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que são moduladas por inibidores de accß e sua utilização
BRPI0413186A (pt) composição de fexofenadina e processo para preparação da mesma
AR056026A1 (es) Derivados de 2-oxo-benzotiazol, como agonistas del adrenoreceptor beta2, un procedimiento para su prepoaracion, composiciones farmaceuticas que los comprenden y su uso en la elaboracion de un medicamento para el tratamiento de enfermedades respiratorias
TW200621313A (en) Pharmaceutical compositions
BRPI0407968A (pt) derivados de oxamida úteis como inibidores de raf-quinase
DE60111352D1 (de) Podophyllotoxin-zusammensetzungen
DK1383756T3 (da) Cumarinderivater til anvendelse som antikoagulanter

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties